Skip to main content
. 2020 Jun 5;3(2):64–68. doi: 10.36401/JIPO-20-3

Table 2.

The targetable mutations that are approved by the Food and Drug Administration or used in the clinical trial European Society for Medical Oncology Scale of Clinical Accountability for molecular targets (ESCAT) and OncoKB

Mutation
ESCAT/OncoKB, Tier
TP53 X
BRAF III
CCNE X
EGFR III
PIK3CA III
FGFR1 III
RB1 X
KIT III
PDGFRA III
RAF1 III
ERBB2 III
MET III